Elucidating Conditions for Trial Termination in Head and Neck Studies
FDA Issues Partial Clinical Hold on Lorigerlimab Trial in Gynecologic Cancers: The Food and Drug Administration has enforced a clinical hold on the ongoing trial of Lorigerlimab against gynecologic cancers.
Refining Management of Immune-Checkpoint Inhibitor Toxicities in Melanoma: New insights into the effective management of immune-checkpoint inhibitor toxicities in Melanoma have emerged.
FDA Grants Fast Track Designation to SRN-101 for Recurrent High-Grade Glioma: In efforts to expedite potential cancer treatments, SRN-101 has been granted fast track designation by the FDA for recurrent high-grade glioma.
Nobel Small Molecule Shows Early Activity in Pretreated Multiple Myeloma: Promising early results have been found in a novel small molecule for the treatment of pre-treated multiple myeloma.
Comparing Quality of Life Outcomes with Protons vs Photons in OPSCC: A comparative study reveals differing outcomes in quality of life with Protons and Photons treatments in OPSCC.
